Neo Ivy Capital Management - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2022$22,000
+144.4%
4,078
+537.2%
0.02%
+53.8%
Q4 2021$9,000
-62.5%
640
-37.1%
0.01%
-53.6%
Q3 2021$24,000
-69.6%
1,017
-78.1%
0.03%
-68.2%
Q4 2020$79,000
+229.2%
4,639
+356.1%
0.09%
+877.8%
Q2 2020$24,000
-42.9%
1,017
-56.9%
0.01%
-86.8%
Q1 2020$42,000
-93.3%
2,357
-87.7%
0.07%
-86.2%
Q4 2018$628,00019,1130.49%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders